JCI - Citations to Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

Citations to this article

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

Terry Hermiston

Terry Hermiston

Published May 1, 2000
Citation Information: J Clin Invest. 2000;105(9):1169-1172. https://doi.org/10.1172/JCI9973.

View: Text | PDF

Total citations by year

Year:	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2006	2005	2004	2003	2002	2001	2000	Total
Citations:	2	3	2	1	1	2	1	2	1	4	1	3	6	7	7	7	7	4	8	18	9	4	100

Citation information

Citations to this article (100)

Title and authors	Publication	Year
Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements. Yun CO, Hong J, Yoon AR	Frontiers in immunology	2022
Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors. Yoon AR, Rivera-Cruz C, Gimble JM, Yun CO, Figueiredo ML		2022
Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer R He, Y Lao, W Yu, X Zhang, M Jiang, C Zhu	Frontiers in Oncology	2021
Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation? S Addou, C Sarkozy, J Lazarovici, S Champiat, A Stamatoullas, F Jardin, V Ribrag, A Marabelle, JM Michot	Human Vaccines & Immunotherapeutics	2021
Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs J Béguin, M Gantzer, I Farine, J Foloppe, B Klonjkowski, C Maurey, É Quéméneur, P Erbs	Scientific Reports	2021
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs V Innao, V Rizzo, AG Allegra, C Musolino, A Allegra	Current Oncology	2020
CRISPR-Cas12a with an oAd Induces Precise and Cancer-Specific Genomic Reprogramming of EGFR and Efficient Tumor Regression AR Yoon, BK Jung, E Choi, E Chung, JW Hong, JS Kim, T Koo, CO Yun	Molecular Therapy	2020
Achieving systemic delivery of oncolytic viruses C Hill, R Carlisle	Expert Opinion on Drug Delivery	2019
Oncolytic virus and PD-1/PD-L1 blockade combination therapy CY Chen, B Hutzen, MF Wedekind, TP Cripe	Oncolytic Virotherapy	2018
Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery D Haddad	Frontiers in Oncology	2017
Combing oncolytic adenovirus expressing Beclin-1 with chemotherapy agent doxorubicin synergistically enhances cytotoxicity in human CML cells in vitro L Li, L You, L Mao, S Jin, X Chen, W Qian	Acta Pharmacologica Sinica	2017
Novel oncolytic viral therapies in patients with thoracic malignancies Z Ahmad, R Kratzke	Oncolytic Virotherapy	2016
Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy S Thorne, P Sampath	Oncolytic Virotherapy	2015
Molecular imaging of oncolytic viral therapy D Haddad, Y Fong	Molecular Therapy — Oncolytics	2015
Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy M Bauzon, T Hermiston	Frontiers in immunology	2014
Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses S Thorne, P Sampath	Oncolytic Virotherapy	2013
Experimental studies on treatment of pancreatic cancer with double-regulated duplicative adenovirus AdTPHre-hEndo carrying human endostatin gene Y Shan, Y Fang, X Wang, R Jin, Q Zhang, R Andersson	Pancreatology	2013
Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia Y Tong, L You, H Liu, L Li, H Meng, Q Qian, W Qian	Oncotarget	2013
Advances in Diagnosis and Management of Ovarian Cancer SA Farghaly		2013
Progress of oncolytic viruses in sarcomas CK Lettieri, P Hingorani, EA Kolb	Expert Review of Anticancer Therapy	2012
Conditionally Replicating Adenovirus Expressing TIMP2 Increases Survival in a Mouse Model of Disseminated Ovarian Cancer SW Yang, D Chanda, JJ Cody, AA Rivera, R Waehler, GP Siegal, JT Douglas, S Ponnazhagan	PloS one	2011
A Potent Oncolytic Adenovirus Selectively Blocks the STAT3 Signaling Pathway and Potentiates Cisplatin Antitumor Activity in Ovarian Cancer Z Han, Z Hong, Q Gao, C Chen, Z Hao, T Ji, W Hu, Y Yan, J Feng, S Liao, P Wu, D Wang, S Wang, J Zhou, D Ma	Human Gene Therapy	2011
Conditionally Replicating Adenovirus Expressing TIMP2 Increases Survival in a Mouse Model of Disseminated Ovarian Cancer SW Yang, D Chanda, JJ Cody, AA Rivera, R Waehler, GP Siegal, JT Douglas, S Ponnazhagan, C Creighton	PloS one	2011
Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer JJ Cody, AA Rivera, GR Lyons, SW Yang, M Wang, DB Sarver, D Wang, KS Selander, HC Kuo, S Meleth, X Feng, GP Siegall, JT Douglas	Cancer Gene Therapy	2010
Oncolytic virotherapy reaches adolescence AM Hammill, J Conner, TP Cripe	Pediatric Blood & Cancer	2010
Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program CL Morton, PJ Houghton, EA Kolb, R Gorlick, CP Reynolds, MH Kang, JM Maris, ST Keir, J Wu, MA Smith	Pediatric Blood & Cancer	2010
A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect AA Paupoo, ZB Zhu, M Wang, DT Rein, A Starzinski-Powitz, DT Curiel	Human reproduction (Oxford, England)	2010
Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF A Koski, L Kangasniemi, S Escutenaire, S Pesonen, V Cerullo, I Diaconu, P Nokisalmi, M Raki, M Rajecki, K Guse, T Ranki, M Oksanen, SL Holm, E Haavisto, A Karioja-Kallio, L Laasonen, K Partanen, M Ugolini, A Helminen, E Karli, P Hannuksela, S Pesonen, T Joensuu, A Kanerva, A Hemminki	Molecular Therapy	2010
Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy SW Yang, JJ Cody, AA Rivera, R Waehler, M Wang, KJ Kimball, RA Alvarez, GP Siegal, JT Douglas, S Ponnazhagan	Clinical cancer research	2010
Armed replicating adenoviruses for cancer virotherapy JJ Cody, JT Douglas	Cancer Gene Therapy	2009
Gene therapy of benign gynecological diseases MH Hassan, EE Othman, D Hornung, A Al-Hendy	Advanced Drug Delivery Reviews	2009
Advancements in adenoviral based virotherapy for ovarian cancer KS Matthews, RD Alvarez, DT Curiel	Advanced Drug Delivery Reviews	2009
Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation T Ritter, U Pleyer	Expert Review of Clinical Immunology	2009
A novel oncolytic adenovirus selectively silences the expression of tumor-associated STAT3 and exhibits potent antitumoral activity Z Han, Z Hong, C Chen, Q Gao, D Luo, Y Fang, Y Cao, T Zhu, X Jiang, Q Ma, W Li, L Han, D Wang, G Xu, S Wang, L Meng, J Zhou, D Ma	Carcinogenesis	2009
In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer M Bauzon, F Jin, P Kretschmer, T Hermiston	Gene Therapy	2009
Reproductive Endocrinology PJ Chedrese		2009
Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors YY Mahller, SS Vaikunth, MC Ripberger, WH Baird, Y Saeki, JA Cancelas, TM Crombleholme, TP Cripe	Cancer research	2008
Imaging of viral thymidine kinase gene expression by replicating oncolytic adenovirus and prediction of therapeutic efficacy EJ Kim, JY Yoo, YH Choi, KJ Ahn, JD Lee, CO Yun, M Yun	Yonsei Medical Journal	2008
Directed evolution generates a novel oncolytic virus for the treatment of colon cancer I Kuhn, P Harden, M Bauzon, C Chartier, J Nye, S Thorne, T Reid, S Ni, A Lieber, K Fisher, L Seymour, GM Rubanyi, RN Harkins, TW Hermiston	PloS one	2008
Implication of functional activity for determining therapeutic efficacy of suicide genes in vitro P Gopinath, SS Ghosh	Biotechnology Letters	2008
Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA JN Zheng, DS Pei, LJ Mao, XY Liu, DD Mei, BF Zhang, Z Shi, RM Wen, XQ Sun	Cancer Gene Therapy	2008
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer I Kuhn, P Harden, M Bauzon, C Chartier, J Nye, S Thorne, T Reid, S Ni, A Lieber, K Fisher, L Seymour, GM Rubanyi, RN Harkins, TW Hermiston, DY Jin	PloS one	2008
Principles of Molecular Oncology MH Bronchud, MA Foote, G Giaccone, O Olopade, P Workman		2008
Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application K Takayama, PN Reynolds, Y Adachi, L Kaliberova, J Uchino, Y Nakanishi, DT Curiel	Cancer Gene Therapy	2006
Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo M Kim, TM Bodenstine, LA Sumerel, AA Rivera, AH Baker, JT Douglas	Cancer biology & therapy	2006
Oncolytic adenovirus-mediated transfer of the antisense chk2 selectively inhibits tumor growth in vitro and in vivo G Chen, J Zhou, Q Gao, X Huang, K Li, L Zhuang, M Huang, G Xu, S Wang, Y Lu, D Ma	Cancer Gene Therapy	2006
Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis R Qi, J Gu, Z Zhang, K Yang, B Li, J Fan, C Wang, Z He, L Qiao, Z Lin, XY Liu	Cancer Gene Therapy	2006
Selective Intratumoral Amplification of an Antiangiogenic Vector by an Oncolytic Virus Produces Enhanced Antivascular and Anti-tumor Efficacy SH Thorne, BY Tam, DH Kirn, CH Contag, CJ Kuo	Molecular Therapy	2006
Gene therapy and uterine leiomyoma: a review A Al-Hendy, S Salama	Human Reproduction Update	2006
Nucleic Acid Therapeutics for Hematologic Malignancies--Theoretical Considerations JB Opalinska, A Kalota, J Chattopadhyaya, M Damha, AM Gewirtz	Annals of the New York Academy of Sciences	2006
Avian adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumors EV Shashkova, LV Cherenova, DB Kazansky, K Doronin	Cancer Gene Therapy	2005
Development of a transposon-based approach for identifying novel transgene insertion sites within the replicating adenovirus PJ Kretschmer, F Jin, C Chartier, TW Hermiston	Molecular Therapy	2005
Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development TW Hermiston, DH Kirn	Molecular Therapy	2005
Identification of novel insertion sites in the Ad5 genome That utilize the Ad splicing machinery for therapeutic gene expression F Jin, PJ Kretschmer, TW Hermiston	Molecular Therapy	2005
Cancer Gene Therapy M Yamamoto, DT Curiel	Technology in cancer research & treatment	2005
Δ24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization C Conrad, CR Miller, Y Ji, C Gomez-Manzano, S Bharara, JS McMurray, FF Lang, F Wong, R Sawaya, WK Yung, J Fueyo	Cancer Gene Therapy	2005
Introduction to the Background, Principles, and State of the Art in Suicide Gene Therapy I Niculescu-Duvaz, CJ Springer	Molecular Biotechnology	2005
Potent antitumor activity after systemic delivery of a doubly fusogenic oncolytic herpes simplex virus against metastatic prostate cancer M Nakamori, X Fu, CA Pettaway, X Zhang	The Prostate	2004
Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murineendostatin in hepatocellular carcinoma G Li, J Sham, J Yang, C Su, H Xue, D Chua, L Sun, Q Zhang, Z Cui, M Wu, Q Qian	International Journal of Cancer	2004
Diagnosis and Management of Ovarian Disorders AB Copperman, T Mukherjee, NG Kase	Diagnosis and Management of Ovarian Disorders	2004
Adenoviruses: Model and Vectors in Virus-Host Interactions W Doerfler, P Böhm		2004
Therapeutic Potential of Antisense Nucleic Acid Molecules JB Opalinska, AM Gewirtz	Science signaling	2003
E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models Y Wang, G Hallden, R Hill, A Anand, TC Liu, J Francis, G Brooks, N Lemoine, D Kirn	Nature Biotechnology	2003
Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis: DM Nettelbeck	Anti-Cancer Drugs	2003
Oncolytic Herpes Viruses as a Potential Mechanism for Cancer Therapy E Lou	Acta Oncologica	2003
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy G Halldén, R Hill, Y Wang, A Anand, TC Liu, NR Lemoine, J Francis, L Hawkins, D Kirn	Molecular Therapy	2003
Multigene expression from a replicating adenovirus using native viral promoters M Bauzon, D Castro, M Karr, LK Hawkins, TW Hermiston	Molecular Therapy	2003
Developing Novel Oncolytic Adenoviruses through Bioselection W Yan, G Kitzes, F Dormishian, L Hawkins, A Sampson-Johannes, J Watanabe, J Holt, V Lee, T Dubensky, A Fattaey, T Hermiston, A Balmain, Y Shen	Journal of virology	2003
Human Gene Therapy: Current Opportunities and Future Trends GM Rubanyi, S Ylä-Herttuala		2003
Genomic Medicine S Alesci, GP Chrousos, K Pacak	Annals of the New York Academy of Sciences	2002
T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis CS Sullivan, JM Pipas	Microbiology and molecular biology reviews : MMBR	2002
Encyclopedia of Cancer G Sgouros	Encyclopedia of Cancer	2002
Ewing Sarcoma Family of Tumors Express Adenovirus Receptors and Are Susceptible to Adenovirus-Mediated Oncolysis AM Rice, MA Currier, LC Adams, NS Bharatan, MH Collins, JD Snyder, J Khan, TP Cripe	Journal of Pediatric Hematology/Oncology	2002
Oncolytic Viruses LK Hawkins, D Kirn		2002
Adenoviral Vectors for Gene Therapy D Kirn	Adenoviral Vectors for Gene Therapy	2002
Gene Therapy of Cancer IV Lebedeva, CA Stein	Gene Therapy of Cancer	2002
Gene Therapy in Lung Disease K Amin	Gene Therapy in Lung Disease	2002
Pediatric oncology: current views and outcomes GH Reaman	Pediatric Clinics of North America	2002
New strategies to enhance gene therapy efficiency C Qian, B Sangro, J Prieto	Gastroenterology	2002
The oncolytic virotherapy treatment platform for cancer: Unique biological and biosafety points to consider R Vile, D Ando, D Kirn	Cancer Gene Therapy	2002
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials T Reid, R Warren, D Kirn	Cancer Gene Therapy	2002
Virotherapy for cancer: Current status, hurdles, and future directions D Kirn	Cancer Gene Therapy	2002
Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes TW Hermiston, I Kuhn	Cancer Gene Therapy	2002
The emerging fields of suicide gene therapy and virotherapy David Kirn, Ion Niculescu-Duvaz, Gunnel Hallden, Caroline J Springer	Trends in Molecular Medicine	2002
Oncolytic biotherapy: a novel therapeutic plafform Lynda K Hawkins, Nick R Lemoine, David Kirn	The Lancet Oncology	2002
A System for Small-Molecule Control of Conditionally Replication-Competent Adenoviral Vectors H Chong, A Ruchatz, T Clackson, VM Rivera, RG Vile	Molecular Therapy	2002
Gene therapy for intraperitoneally disseminated pancreatic cancers byEscherichia coli uracil phosphoribosiltransferase (UPRT) gene mediated by restricted replication-competent adenoviral vectors M Oonuma, M Sunamura, F Motoi, S Fukuyama, H Shimamura, J Yamauchi, K Shibuya, S Egawa, H Hamada, K Takeda, S Matsuno	International Journal of Cancer	2002
GENETHERAPY: Promises and Problems A Pfeifer, IM Verma	Annual Review of Genomics and Human Genetics	2001
Intracellular Drug Delivery. Workshop Report from the 28th International Symposium on Controlled Release of Bioactive Materials, San Diego, 23-24 June 2001 AT Jones	Traffic	2001
EXLOITING GENETIC ALTERATIONS TO DESIGN NOVEL THERAPIES FOR CANCER TP Cripe, CL Mackall	Hematology/Oncology Clinics of North America	2001
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region LK Hawkins, TW Hermiston	Gene Therapy	2001
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region LK Hawkins, L Johnson, M Bauzon, JA Nye, D Castro, GA Kitzes, MD Young, JK Holt, P Trown, TW Hermiston	Gene Therapy	2001
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region LK Hawkins, T Hermiston	Gene Therapy	2001
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy ES Lambright, K Amin, R Wiewrodt, SD Force, M Lanuti, KJ Propert, L Litzky, LR Kaiser, SM Albelda	Gene Therapy	2001
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics MA Kay, JC Glorioso, L Naldini	Nature Medicine	2001
Evaluation of a new dual-specificity promoter for selective induction of apoptosis in breast cancer cells R Hernandez-Alcoceba, M Pihalja, G Nunez, MF Clarke	Cancer Gene Therapy	2001
Prodrug-activating systems in suicide gene therapy CJ Springer, I Niculescu-Duvaz	Journal of Clinical Investigation	2000
Cancer gene therapy: developments to 2000 AR Bateman, KJ Harrington, AA Melcher, RG Vile	Expert Opinion on Investigational Drugs	2000
Conditionally replicative adenoviral vectors for cancer gene therapy J Gómez, DT Curiel	The Lancet Oncology	2000
Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer D Kirn	Oncogene	2000

Advertisement